Not that I'm aware of...I thought the article mentioned 3 to 5 years out

"Our aim is to change the current state of neuropathy in three to five years by bringing to market hope for peripheral neuropathy sufferers. WinSanTor’s lead compound, WST-057, shows the ability to prevent nerve damage and re-grow damaged nerves. With its well-known safety profile, WST-057 is on track to an accelerated regulatory approval and to the clinic." --- https://winsantor.com/pipeline/